News|Articles|March 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-03-02-2004
  • Volume 28
  • Issue 3

March 2003

Pharmaceutical science and technology news


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.